Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and esomeprazole in early onset preeclampsia
NCT03717701Unknown
- Sponsor
- Aswan University Hospital
- Start
- Dec 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of liquid metformin (Aspargo Labs) and esomeprazole in preeclampsia (2 arms), sponsored by Aswan University Hospital. Primary endpoint: Prolongation of gestation at 4 weeks. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)esomeprazole
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03717701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03717701.